[ICAM-1 antisense therapy: a new treatment concept on Crohn disease? Placebo controlled study of ICAM-1 antisense oligonucleotide therapy in Crohn disease].
Martignoni
M E
ME
Klinik für Viszeralchirurgie, Inselspital Bern.
Friess
H
H
D000328:Adult; D000368:Aged; D003424:Crohn Disease / Q000235:genetics / Q000628:therapy*; D004311:Double-Blind Method; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*
D016376:Oligonucleotides, Antisense; D018799:Intercellular Adhesion Molecule-1
ICAM-l-Antisense-Therapie: Ein neues Behandlungskonzept beim M. Crohn? Plazebokontrollierte Studie einer ICAM-l-Antisense-Oligonukleotidtherapie beim M. Crohn.